SchizophreniaNCT01170689
The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
An observational study of Schizophrenia and Obesity, run by TsaoTun Psychiatric Center, Department of Health, Taiwan at 1 site in Taiwan.
Trial summary
This study is the first hospital-based, cross-sectional study to discuss the prevalence of obesity among 710 inpatients with schizophrenia. Read more about this study
- Who is it for?
- Ages 20 to 72 years
- Conditions the study is for
- Schizophrenia, Obesity
- How many people
- 710 participants
- Where
- 1 siteTaiwan
- Study dates
- Mar 2010to Mar 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 72 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 710 adult schizophrenia patients living in the chronic ward in Tsau-Tun psychiatric center during the first week in March 2010
Who may be able to join
- diagnosis as ICD 295
- Living in rehabilitation ward during 2010/03/22~2010/04/02
Who cannot join
- none
Trial locations and contacts
1 site in 1 country.
About this study
This study is the first hospital-based, cross-sectional study to discuss the prevalence of obesity among 710 inpatients with schizophrenia.
- Conditions
- Schizophrenia, Obesity
- Keywords
- Schizophrenia, inpatient, obesity, prevalence
- Medical subject headings
- Schizophrenia, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Inpatient schizophrenia or schizoaffective disorder | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body mass index (BMI)
Measured: cross-sectional study, check one time
Secondary outcomes (1)
waist circumference
Measured: cross-sectional study, check for one time
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jul 2010 (estimated)
- Study startMar 2010
- Primary completionMar 2010
- Study completionMar 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SchizophreniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 710 participants (actual)
Sponsor and investigators
- Lead sponsor
- TsaoTun Psychiatric Center, Department of Health, Taiwan
- Sponsor type
- University, hospital or other
- Investigators
- Ching Han-Yi, MD, Principal investigator, Tsaotun Psychiatric Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01170689
- Sponsor's protocol ID
- Tsao-Tun Psychiatric Center
- Status last verified
- Jul 2010
- First submitted
- 26 Jul 2010
- Last updated
- 28 Jul 2010
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
- ClinicalTrials.gov ID
- NCT01170689
- Acronym / sponsor ID
- Tsao-Tun Psychiatric Center
- Conditions
- Schizophrenia, Obesity
- Keywords
- Schizophrenia, inpatient, obesity, prevalence
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 710 participants (actual)
- Lead sponsor
- TsaoTun Psychiatric Center, Department of Health, TaiwanUniversity, hospital or other
- Study start
- Mar 2010
- Primary completion
- Mar 2010 (actual)
- Study completion
- Mar 2010 (actual)
- First posted
- 27 Jul 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is the first hospital-based, cross-sectional study to discuss the prevalence of obesity among 710 inpatients with schizophrenia.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Inpatient schizophrenia or schizoaffective disorder | – | – |
Who may qualify
- Ages
- 20 to 72 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 710 adult schizophrenia patients living in the chronic ward in Tsau-Tun psychiatric center during the first week in March 2010
Key inclusion criteria (2 listed)
- diagnosis as ICD 295
- Living in rehabilitation ward during 2010/03/22~2010/04/02
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Body mass index (BMI)
Time frame: cross-sectional study, check one time
1 secondary outcome
waist circumference
Time frame: cross-sectional study, check for one time
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2010.
Related trials for Schizophrenia
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Deep Brain Stimulation for Treatment-Resistant Schizophrenia
Treatment Resistant Disorders
Not yet recruitingObservational study
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingPhase 1
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
Healthy Adult Participants
Active, not recruiting
Designing and Evaluating a Classroom-Based Mental Health Programme for Adolescents.
Mental Health Promotion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ching Han-Yi, MD principal investigator
Tsaotun Psychiatric Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Schizophrenia and Obesity, run by TsaoTun Psychiatric Center, Department of Health, Taiwan at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body mass index (BMI) (time frame: cross-sectional study, check one time). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2010.